LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting
ACS Pharmacology & Translational Science · 10.10.2025 · 8 (10) · 3654-3668
DOI: 10.1021/acsptsci.5c00537 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 30.09.2025. Verfasst von Antonella Rocchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Transcan, Consiglio Nazionale delle Ricerche, Estonian Research Competency Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia.
- Department of Pharmacy, University of Chieti - Pescara "G. d'Annunzio", Via dei Vestini 31, Chieti 66100, Italy.
- Division of GI/Endocrine Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York 10032, United States.
- Department of Clinical and Experimental Medicine, University of Catanzaro "Magna Græcia", V.le "S. Venuta", Catanzaro I-88100, Italy.
- Research Center "ProHealth Translational Hub", Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Campus Universitario "S. Venuta" - Building of BioSciences, Viale S. Venuta, Cata…
- Department of Health Science, University of Catanzaro "Magna Græcia", V.le "S. Venuta", Catanzaro I-88100, Italy.
ORCID-Profile: Antonella Rocchi, Massimo Fresta, Christian Celia
Förderung
- Transcan
- Consiglio Nazionale delle Ricerche
- Estonian Research Competency Council
- Ministero dell'Universit? e della Ricerca
- EuroNanoMed III
- NextGenerationEU
Zitieren
APA
Rocchi, A., Sidorenko, V., d'Avanzo, N., Marchetti, L., Sethi, J., Ciriolo, L., Tolomeo, A. M., Cifone, M. G., Palumbo, P., Fresta, M., Teesalu, T., & Celia, C. (2025). LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting. ACS Pharmacology & Translational Science, 8(10), 3654-3668. https://doi.org/10.1021/acsptsci.5c00537
Vancouver
Rocchi A, Sidorenko V, d'Avanzo N, Marchetti L, Sethi J, Ciriolo L, et al. LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting. ACS Pharmacology & Translational Science. 2025;8(10):3654-3668. doi:10.1021/acsptsci.5c00537
BibTeX
@article{Rocchi2025,
author = {Rocchi, Antonella and Sidorenko, Valeria and d'Avanzo, Nicola and Marchetti, Luca and Sethi, Jhalak and Ciriolo, Luigi and Tolomeo, Anna Maria and Cifone, Maria Grazia and Palumbo, Paola and Fresta, Massimo and Teesalu, Tambet and Celia, Christian},
title = {LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting},
journal = {ACS Pharmacology & Translational Science},
year = {2025},
volume = {8},
number = {10},
pages = {3654--3668},
doi = {10.1021/acsptsci.5c00537}
}
EUVIMED